Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Results of a Prospective, Multinational Registry

Background— The risks of sports participation for implantable cardioverter-defibrillator (ICD) patients are unknown. Methods and Results— Athletes with ICDs (age, 10–60 years) participating in organized (n=328) or high-risk (n=44) sports were recruited. Sports-related and clinical data were obtained by phone interview and medical records. Follow-up occurred every 6 months. ICD shock data and clinical outcomes were adjudicated by 2 electrophysiologists. Median age was 33 years (89 subjects <20 years of age); 33% were female. Sixty were competitive athletes (varsity/junior varsity/traveling team). A pre-ICD history of ventricular arrhythmia was present in 42%. Running, basketball, and soccer were the most common sports. Over a median 31-month (interquartile range, 21–46 months) follow-up, there were no occurrences of either primary end point—death or resuscitated arrest or arrhythmia- or shock-related injury—during sports. There were 49 shocks in 37 participants (10% of study population) during competition/practice, 39 shocks in 29 participants (8%) during other physical activity, and 33 shocks in 24 participants (6%) at rest. In 8 ventricular arrhythmia episodes (device defined), multiple shocks were received: 1 at rest, 4 during competition/practice, and 3 during other physical activity. Ultimately, the ICD terminated all episodes. Freedom from lead malfunction was 97% at 5 years (from implantation) and 90% at 10 years. Conclusions— Many athletes with ICDs can engage in vigorous and competitive sports without physical injury or failure to terminate the arrhythmia despite the occurrence of both inappropriate and appropriate shocks. These data provide a basis for more informed physician and patient decision making in terms of sports participation for athletes with ICDs.

[1]  Wojciech Zareba,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.

[2]  Hein Heidbuchel,et al.  Ventricular arrhythmias associated with long-term endurance sports: what is the evidence? , 2012, British Journal of Sports Medicine.

[3]  M. Barry,et al.  Shared decision making--pinnacle of patient-centered care. , 2012, The New England journal of medicine.

[4]  A. Zwinderman,et al.  Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  R. Duncan,et al.  Adolescents with Implantable Cardioverter Defibrillators: A Patient and Parent Perspective , 2012, Pacing and clinical electrophysiology : PACE.

[6]  A. Skanes,et al.  Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. , 2011, Heart rhythm.

[7]  W. Maisel,et al.  34 – Guidelines for Managing Pacemaker and Implantable Defibrillator Advisories , 2011 .

[8]  P. Heidenreich,et al.  Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.

[9]  Vicki L Zeigler,et al.  Determining Psychosocial Research Priorities for Adolescents With Implantable Cardioverter Defibrillators Using Delphi Methodology , 2010, The Journal of cardiovascular nursing.

[10]  L. Salberg,et al.  Patient Advocacy: What Is Its Role? , 2009, Pacing and clinical electrophysiology : PACE.

[11]  Stephen L Moore,et al.  Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.

[12]  J. Triedman,et al.  Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. , 2008, Journal of the American College of Cardiology.

[13]  A. Moss,et al.  Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. , 2007, Heart rhythm.

[14]  V. Shusterman,et al.  Implantable Cardioverter‐Defibrillator Shocks Increase T‐Wave Alternans , 2007, Journal of cardiovascular electrophysiology.

[15]  Angelo Auricchio,et al.  Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy , 2007 .

[16]  G. Breithardt,et al.  Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice , 2006, Circulation.

[17]  Pietro Delise,et al.  Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions Part II: Ventricular arrhythmias, channelopathies and implantable defibrillators , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[18]  D. Cannom,et al.  Safety of Sports Participation in Patients with Implantable Cardioverter Defibrillators: 
A Survey of Heart Rhythm Society Members , 2006, Journal of cardiovascular electrophysiology.

[19]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[20]  R. Bonow,et al.  36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes With Cardiovascular Abnormalities , 2005 .

[21]  M. Link,et al.  Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.

[22]  Maurizio Schiavon,et al.  Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[23]  L. Fananapazir,et al.  Efficacy of Implantable Cardioverter Defibrillator Therapy for Primary and Secondary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy , 2003, Pacing and clinical electrophysiology : PACE.

[24]  H. Heidbuchel,et al.  High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. , 2003, European heart journal.

[25]  A. Moss,et al.  Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients , 2003, Journal of cardiovascular electrophysiology.

[26]  Diwakar Jain,et al.  Emotional and Physical Precipitants of Ventricular Arrhythmia , 2002, Circulation.

[27]  J. Kluger,et al.  Ineffective ICD Therapy Due to Excessive Alcohol and Exercise , 2002, Pacing and clinical electrophysiology : PACE.

[28]  R. Ideker,et al.  Impact of Myocardial Ischemia and Reperfusion on Ventricular Defibrillation Patterns, Energy Requirements, and Detection of Recovery , 2002, Circulation.

[29]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[30]  Judy Powell,et al.  Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial: Impact of Therapy and Influence of Adverse Symptoms and Defibrillator Shocks , 2002, Circulation.

[31]  A. Motamedi,et al.  Quality of Life Assessment in Elite Collegiate Athletes * , 2001, The American journal of sports medicine.

[32]  M. Link,et al.  Report of the NASPE Policy Conference on Arrhythmias and the Athlete , 2001, Journal of cardiovascular electrophysiology.

[33]  Y. Deychak,et al.  Electrophysiologic basis by which epinephrine facilitates defibrillation after prolonged episodes of ventricular fibrillation. , 2001, Annals of emergency medicine.

[34]  D. Wyse,et al.  Electrical Storm Presages Nonsudden Death: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial , 2001, Circulation.

[35]  B. Maron,et al.  The paradox of exercise. , 2000, The New England journal of medicine.

[36]  J. Manson,et al.  Triggering of sudden death from cardiac causes by vigorous exertion. , 2000, The New England journal of medicine.

[37]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[38]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[39]  C. Schuger,et al.  Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses. , 1999, Journal of the American College of Cardiology.

[40]  F O Mueller,et al.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.

[41]  H. Calkins,et al.  Effect of epinephrine on the efficacy of the internal cardioverter-defibrillator. , 1992, The American journal of cardiology.

[42]  O. Sejersted,et al.  Plasma potassium changes with high intensity exercise. , 1990, The Journal of physiology.